Medical Education Library
Combination hormonal contraception
and venous thromboembolism risk
This supplement was sponsored by and developed in conjunction with Ortho Women’s Health & Urology™, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Although venous thromboembolism (VTE) is a rare event in young reproductive-age women, users of combination oral contraceptives are at increased risk. This supplement builds awareness of VTE risk factors and reviews contraceptive options for at-risk patients.
Full text | PDF